Cargando…
HIV-1 Entry and Prospects for Protecting against Infection
Human Immunodeficiency Virus type-1 (HIV-1) establishes a latent viral reservoir soon after infection, which poses a major challenge for drug treatment and curative strategies. Many efforts are therefore focused on blocking infection. To this end, both viral and host factors relevant to the onset of...
Autores principales: | Bruxelle, Jean-François, Trattnig, Nino, Mureithi, Marianne W., Landais, Elise, Pantophlet, Ralph |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7911371/ https://www.ncbi.nlm.nih.gov/pubmed/33499233 http://dx.doi.org/10.3390/microorganisms9020228 |
Ejemplares similares
-
Synthesis
of an Undecasaccharide Featuring an Oligomannosidic
Heptasaccharide and a Bacterial Kdo-lipid A Backbone for Eliciting
Neutralizing Antibodies to Mammalian Oligomannose on the HIV-1
Envelope Spike
por: Trattnig, Nino, et al.
Publicado: (2019) -
Serum alpha-mannosidase as an additional barrier to eliciting oligomannose-specific HIV-1-neutralizing antibodies
por: Bruxelle, Jean-François, et al.
Publicado: (2020) -
A glycoside analog of mammalian oligomannose formulated with a TLR4-stimulating adjuvant elicits HIV-1 cross-reactive antibodies
por: Bruxelle, Jean-François, et al.
Publicado: (2021) -
Comparative Antigenicity of Thiourea and Adipic Amide
Linked Neoglycoconjugates Containing Modified Oligomannose Epitopes
for the Carbohydrate-Specific anti-HIV Antibody 2G12
por: Trattnig, Nino, et al.
Publicado: (2018) -
Bacterially derived synthetic mimetics of mammalian oligomannose prime antibody responses that neutralize HIV infectivity
por: Pantophlet, Ralph, et al.
Publicado: (2017)